Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Diagnosis, Computer-Assisted × 90 days × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Melanoma 1 Disease 1

Interventions

pembrolizumab 69 Cyclophosphamide 42 Nivolumab 40 Cisplatin 36 Carboplatin 32 Paclitaxel 29 Radiotherapy 24 Gemcitabine 23 Dexamethasone 22 fludarabine 21 Ipilimumab 20 Blood Specimen Collection 19 Cetuximab 18 atezolizumab 17 Doxorubicin 17 Docetaxel 17 Surveys and Questionnaires 16 Standard of Care 16 Prednisone 16 Lenalidomide 16 Irinotecan 16 Fluorouracil 15 lenvatinib 14 Trastuzumab 14 Oxaliplatin 14 regorafenib 13 Rituximab 13 Pemetrexed 13 Etoposide 13 Cytarabine 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06221397 2026-03-16

LEGIT_MC_EVCDA

AI Labs Group S.L

105 enrolled 15 charts

Disease, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡